Stocksigma LogoStocksigma Logo

Sai Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

■ Revenue: 6,586 (+22.5% YoY | +18.8% QoQ) ■ EBITDA: 1,864 (+27.8% YoY | +25.9% QoQ) ■ EBITDA Margin (%): 28.3 (+117 bps YoY | +160 bps QoQ) ■ PAT: 983

Sai Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

Sai Life Sciences Ltd · Outcome · 06 Nov 2026, 4:18 am

Sai Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 6,586 (+22.5% YoY | +18.8% QoQ) ■ EBITDA: 1,864 (+27.8% YoY | +25.9% QoQ) ■ EBITDA Margin (%): 28.3 (+117 bps YoY | +160 bps QoQ) ■ PAT: 983 (+17.3% YoY | +34.2% QoQ) ■ EPS (INR): 4.58 (+16.5% YoY | +33.9% QoQ)

Original exchange filing (PDF)

More announcements from Sai Life Sciences Ltd

All Sai Life Sciences Ltd announcements